Lysophosphatidic acid shifts metabolic and transcriptional landscapes to induce a distinct cellular state in human pluripotent stem cells

Cell Rep. 2021 Nov 30;37(9):110063. doi: 10.1016/j.celrep.2021.110063.

Abstract

Pluripotent stem cells (PSCs) can be maintained in a continuum of cellular states with distinct features. Exogenous lipid supplements can relieve the dependence on de novo lipogenesis and shift global metabolism. However, it is largely unexplored how specific lipid components regulate metabolism and subsequently the pluripotency state. In this study, we report that the metabolic landscape of human PSCs (hPSCs) is shifted by signaling lipid lysophosphatidic acid (LPA), which naturally exists. LPA leads to a distinctive transcriptome profile that is not associated with de novo lipogenesis. Although exogenous lipids such as cholesterol, common free fatty acids, and LPA can affect cellular metabolism, they are not necessary for maintaining primed pluripotency. Instead, LPA induces distinct and reversible phenotypes in cell cycle, morphology, and mitochondria. This study reveals a distinct primed state that could be used to alter cell physiology in hPSCs for basic research and stem cell applications.

Keywords: LPA; cellular state; hPSC; lipid; metabolism; mitochondria; pluripotency; transcriptome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cholesterol / pharmacology
  • Fatty Acids, Nonesterified / pharmacology
  • Gene Expression Regulation / drug effects*
  • HEK293 Cells
  • Humans
  • Lipogenesis*
  • Lysophospholipids / pharmacology*
  • Mitochondria / metabolism*
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / metabolism*
  • Transcriptome*

Substances

  • Fatty Acids, Nonesterified
  • Lysophospholipids
  • Cholesterol
  • lysophosphatidic acid